Okell, Thomas W.
Harston, George W. J. http://orcid.org/0000-0003-4916-5757
Chappell, Michael A.
Sheerin, Fintan
Kennedy, James
Jezzard, Peter
Funding for this research was provided by:
Royal Academy of Engineering (RF/132)
Wellcome Trust (WT088877/Z/09/Z and 203139/Z/16/Z)
DH | National Institute for Health Research
Dunhill Medical Trust (OSRP1/1006)
RCUK | Engineering and Physical Sciences Research Council (WT088877/Z/09/Z)
Article History
Received: 1 February 2019
Accepted: 14 May 2019
First Online: 3 June 2019
Competing Interests
: Dr. Chappell and Dr. Okell are authors on a US patent (Number 9,757,047) pertaining to the maximum a posteriori vessel-encoded analysis technique used in this study that has been exclusively licensed to Siemens Healthcare. Dr. Chappell has also received royalties for commercial licenses from the FMRIB software library. Dr. Harston is employed part-time by Brainomix Limited. All other authors declare that they have no conflict of interest.